AIIMS Delhi to start second dose trial of Bharat Biotech’s Covaxin on 2-6 years old children by next week
All India Institute of Medical Sciences (AIIMS) in New Delhi will commence the second dose trial…
Covaxin is 77.8% effective, gives 65.2% Protection against Delta variant, says Bharat Biotech
Phase-III trials of Covaxin, made by Hyderabad’s Bharat Biotech, showed it was 93.4% effective against severe…